Bio Green Med Solution, Inc. — SC 13G/A Filings
41 SC 13G/A filings on record
This page lists all SC 13G/A filings submitted to the SEC by Bio Green Med Solution, Inc. (BGMSP), sorted by most recent first. Each row links to the full filing on EdgarLookup. Bio Green Med Solution, Inc. has filed 41 SC 13G/A documents with the SEC since 2009. To view all SEC filings by Bio Green Med Solution, Inc., see the full filings list.
All
10-K
10-K/A
10-Q
10-Q/A
3
3/A
4
4/A
424B2
424B3
424B4
424B5
425
5
8-A12G
8-K
8-K/A
ARS
CORRESP
CT ORDER
D
DEF 14A
DEF 14C
DEFA14A
DEFR14A
DRS
EFFECT
FWP
NT 10-K
NT 10-Q
POS AM
PRE 14A
PRE 14C
PRER14A
REGDEX
RW
S-1
S-1/A
S-1MEF
S-3
S-3/A
S-4
S-4/A
S-8
S-8 POS
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC 14F1
SCHEDULE 13D
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SC 13G/A | — | 0000929638-24-003924 | Nov 14, 2024 | — |
| SC 13G/A | — | 0001193805-24-000224 | Feb 14, 2024 | — |
| SC 13G/A | — | 0001943462-24-000001 | Feb 14, 2024 | — |
| SC 13G/A | AMENDMENT TO FORM SC 13G | 0001999371-24-002111 | Feb 13, 2024 | — |
| SC 13G/A | CYCLACEL PHARMACEUTICALS, INC. | 0000902664-24-001230 | Feb 7, 2024 | — |
| SC 13G/A | — | 0001943462-23-000001 | Feb 13, 2023 | — |
| SC 13G/A | SC 13G/A | 0001178913-23-000388 | Feb 6, 2023 | — |
| SC 13G/A | CYCLACEL PHARMACEUTICALS, INC. | 0000902664-23-000736 | Jan 26, 2023 | — |
| SC 13G/A | SC 13G/A | 0001193125-22-041918 | Feb 14, 2022 | — |
| SC 13G/A | SC 13G/A | 0001178913-22-000598 | Feb 14, 2022 | — |
| SC 13G/A | CYCC 13G/A | 0001393825-22-000099 | Feb 4, 2022 | — |
| SC 13G/A | SC 13G/A | 0001104659-21-023226 | Feb 16, 2021 | — |
| SC 13G/A | — | 0001037389-21-000090 | Feb 10, 2021 | — |
| SC 13G/A | CYCC 13GA | 0001393825-21-000026 | Feb 9, 2021 | — |
| SC 13G/A | SCHEDULE 13 G/A | 0001408408-20-000023 | May 5, 2020 | — |
| SC 13G/A | SCHEDULE 13G/A | 0001408408-17-000025 | Aug 25, 2017 | — |
| SC 13G/A | 13G/A | 0001408408-17-000007 | Feb 14, 2017 | — |
| SC 13G/A | SC 13G/A | 0001104659-16-096261 | Feb 12, 2016 | — |
| SC 13G/A | SABBY 13G-A CYCC 1.12.16 | 0001535610-16-000111 | Jan 12, 2016 | — |
| SC 13G/A | — | 0001408408-15-000017 | Mar 11, 2015 | — |
| SC 13G/A | — | 0001408408-15-000011 | Feb 13, 2015 | — |
| SC 13G/A | AMENDMENT NO. 2 | 0001214659-14-000377 | Jan 16, 2014 | — |
| SC 13G/A | CYCLACEL 13G/A | 0001425738-13-000017 | Oct 3, 2013 | — |
| SC 13G/A | AMENDMENT NO. 1 | 0001214659-13-001798 | Apr 2, 2013 | — |
| SC 13G/A | CYCLACEL 13G/A | 0001044321-11-000207 | Nov 8, 2011 | — |
| SC 13G/A | CYCLACEL PHARM 13G/A | 0001044321-11-000173 | Aug 9, 2011 | — |
| SC 13G/A | — | 0001044321-11-000062 | Feb 11, 2011 | — |
| SC 13G/A | SC 13G/A | 0001104659-11-006832 | Feb 11, 2011 | — |
| SC 13G/A | — | 0001044321-10-000199 | Dec 2, 2010 | — |
| SC 13G/A | — | 0001044321-10-000172 | Oct 12, 2010 | — |
| SC 13G/A | — | 0001193805-09-000380 | Feb 13, 2009 | — |
| SC 13G/A | — | 0001193805-08-000865 | Mar 14, 2008 | — |
| SC 13G/A | SCHEDULE 13G AMENDMENT NO. 2 | 0001193125-08-031012 | Feb 14, 2008 | — |
| SC 13G/A | — | 0001193805-08-000608 | Feb 14, 2008 | — |
| SC 13G/A | AMENDMENT NO. 1 | 0001193805-07-000419 | Feb 13, 2007 | — |
| SC 13G/A | SCHEDULE 13G/A #2 | 0000950005-06-000641 | Dec 8, 2006 | — |
| SC 13G/A | — | 0000903423-06-000171 | Feb 14, 2006 | — |
| SC 13G/A | XCYTE THERAPIES, INC. | 0000902664-06-000544 | Feb 13, 2006 | — |
| SC 13G/A | AMENDMENT TO SCHEDULE 13G | 0000950134-06-002597 | Feb 13, 2006 | — |
| SC 13G/A | — | 0001044321-05-000243 | Dec 8, 2005 | — |
| SC 13G/A | — | 0001044321-05-000042 | Feb 11, 2005 | — |